BIOENGINEER.ORG

So-called "triple-negative" breast cancer is a particularly aggressive and difficult-to-treat form. It accounts for only about 10 percent of breast cancer cases, but is responsible...

WEST LAFAYETTE, Ind. - Purdue University researchers have found a method of identifying biological markers in small amounts of blood that they believe could be...

Columbus, Ohio - A new study by researchers at The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute (OSUCCC...

Credit: SBP La Jolla, Calif., November 20, 2017 - Researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) have led a preclinical study demonstrating that...

LUGANO, Switzerland - The relentless efforts devoted to improving prevention, early detection, and treatment have resulted in more and more cancer survivors worldwide. In fact,...

LUGANO, 17 November 2017 - Just one in five Indonesian women are aware of cervical cancer screening, according to a study presented at the ESMO...

LUGANO, 17 November 2017 - A study in Myanmar has found that all mouth cancer patients use smokeless tobacco, researchers report at the ESMO Asia...

LUGANO, 17 November 2017 - A study that looked at mainstreaming genetic counselling for ovarian cancer to support screening programmes in Malaysia was presented at...

Credit: UNC Lineberger CHAPEL HILL - A University of North Carolina Lineberger Comprehensive Cancer Center-led study has demonstrated the ability of cognitive computing to scour...

In recognition of their contributions to basic, translational, and clinical research, six faculty members from The University of Texas MD Anderson Cancer Center have been...

Researchers at Cardiff University have found a way to boost the cancer-destroying ability of the immune system's T-cells, offering new hope in the fight against...

The issue was guest edited by Ron Allison (The Brody School of Medicine, USA) who stated: "Imagine a tumor lighting up for the surgeon to...

The Prostate Health Index (phi) is a cost-effective tool used by urologists to detect prostate cancer. It reduces the risk of over diagnosis, and cuts...

LUGANO, 20 November 2017 - A randomised trial in 650 patients has confirmed the safety and efficacy of a new second line treatment for metastatic...

LUGANO, 20 November 2017 - Osimertinib improves progression-free survival compared to standard first line therapy in Asian patients with EGFR-mutated non-small-cell lung cancer (NSCLC), according...